OrbiMed’s Pfenex Inc. PFNX Stock Holding History

OrbiMed’s Portfolio PFNX Stock Details PFNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-1,305,034	Closed	-$11.5M	–	166
2020 Q1	$11.5M	Buy	1,305,034 +690,166	+112%	+$7.58M	0.19%	82
2019 Q4	$6.75M	Buy	+614,868	New	+$6.11M	0.1%	92

Other funds holding PFNX

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RCMC

RK Capital Management (Colorado) Denver, Colorado $324K AUM 47.52% 1-Year Est. Return

TAM

Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

OrbiMed's PFNX Position: Q2 2020 in Review

OrbiMed sold out of Pfenex Inc. (PFNX) in Q2 2020, closing a stake of 1,305,034 shares — an estimated $11.5M sold.

OrbiMed first reported a position in PFNX in Q4 2019 and held it in 2 quarters. The position peaked at $11.5M in Q1 2020. 85 funds tracked by Wall St. Rank hold PFNX as of Q2 2020.

OrbiMed reported no remaining Pfenex Inc. position as of Q2 2020 after selling out during the quarter.
OrbiMed sold 1,305,034 Pfenex Inc. shares in Q2 2020, an estimated $11.5M.
OrbiMed first reported a position in Pfenex Inc. in Q4 2019 and held it in 2 quarters.
OrbiMed's Pfenex Inc. position peaked at $11.5M in Q1 2020.
85 funds tracked by Wall St. Rank held Pfenex Inc. as of Q2 2020.

Based on OrbiMed's 13F filing for Q2 2020, filed 14 Aug 2020.